Mechanism and Molecular Recognition in Human Pyruvate Dehydrogenase Complex
Mechanism and Molecular Recognition in Human Pyruvate Dehydrogenase Complex
批准号:
7624775
负责人:
MULCHAND S PATEL
金额:
$19.81万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2010-05-31
关键词:
AbbreviationsAcetyl Coenzyme AActive SitesAffinity ChromatographyAmino AcidsArtsBacillus stearothermophilusBindingBinding ProteinsBiochemicalBiological AssayBrainCalorimetryCarbohydratesCarbonCardiovascular DiseasesCatalysisCessation of lifeChildChronic DiseaseCircular DichroismCommunicationComplexDailyDataDepthDevelopmentDiseaseEnzymesEscherichia coliEukaryotaEukaryotic CellFamilyGel ChromatographyGene MutationGoalsHomeostasisHumanIndividualIntakeInvestigationIsoenzymesKeto AcidsKineticsLaboratoriesLiteratureMass Spectrum AnalysisMental RetardationMethodsMonitorMutationNeuraxisNeurodegenerative DisordersNon-Insulin-Dependent Diabetes MellitusObesityOrganismOxidoreductasePDH kinasePathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPlayProcessProductionProtein DephosphorylationProtein IsoformsProteinsPyruvatePyruvate DecarboxylasePyruvate Dehydrogenase (Lipoamide)-PhosphatasePyruvate Dehydrogenase ComplexPyruvatesPyruvic AcidRateReactionRegulationReportingRoleSite-Directed MutagenesisSkeletonSpecificityStructureSurface Plasmon ResonanceTechniquesTextThiamine PyrophosphateTimeTitrationsUltracentrifugationWernicke-Korsakoff SyndromeYeastsanalogbasedesiredihydrolipoamide dehydrogenasedihydrolipoyllysine-residue acetyltransferaseinstrumentationionizationmembermolecular recognitionoxidationprotein protein interactionpyruvate dehydrogenasepyruvate dehydrogenase complex E2pyruvate dehydrogenase kinase 4three dimensional structuretool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human pyruvate dehydrogenase complex (hPDC) plays a gatekeeper¿s role in the oxidation of pyruvate
derived from carbohydrates and the carbon-skeletons of several amino acids, and about 50 percent of daily
calorie intake (in term of carbon-flux) is regulated by this enzyme. hPDC is composed of multiple copies of
three catalytic components: heterotetrameric (a2¿2) pyruvate dehydrogenase (PDH), dihydrolipoamide
acetyltransferase (E2) and dihydrolipoamide dehydrogenase (E3); E3-binding protein (BP), and two
regulatory enzymes: PDH kinase (PDK, 4 isoenzymes) and phosphatase, (PDP, 2 isoenzymes). Genetic
defects in PDC components have illustrated the importance of PDC in energy homeostasis and cause
impaired brain development, mental retardation and often early death in children. Reductions in PDC
component proteins and activity levels are observed in chronic diseases such as type 2 diabetes, obesity
and cardiovascular diseases and also in neurodegenerative diseases such as Alzheimer¿s disease,
Parkinson¿s disease and Wernicke-Korsakoff syndrome. hPDC has evolved to unique structural
organization over prokaryotic PDCs and other members of the a-keto acid dehydrogenase complex family
from all species by having BP as additional component and a highly sophisticated mechanism of regulation
by multiple isoenzymes of PDKs and PDPs. Recently, we have solved the 3-D structures of human PDH
and also of human E3 bound to the E3-binding domain of BP. Based on these developments our three
specific aims are to (i) investigate the formation of intermediates in the catalysis of human PDH, (ii)
investigate the active site communication in hPDH, and (iii) determine the loci of interactions between hE3
and hBP and also between hE2 and hBP. Site-directed mutagenesis will be employed to introduce desired
mutations and human proteins will be over-expressed and purified by affinity chromatography. We will
employ the state-of-art instrumentation (such as circular dichroism, 1H NMR, mass spectrometry, rapid
stopped-flow circular dichroism, and isothermal titration calorimetry) and chemically synthesized analogs to
identify and monitor the intermediates of the PDH reaction. The time-course analysis of the intermediates of
PDH reaction will allow us to determine function of individual amino acid residues in catalysis and to
characterize the mechanism of communication (flip-flop mechanism) between the two active sites. The roles
of specific amino acid residues of hBP and hE3 as well as of hBP and hE2 in protein-protein interactions will
be determined by kinetic analysis, gel filtration assay, surface plasmon resonance, isothermal titration
calorimetry and ultracentrifugation. The proposed studies combine the extensive expertise of two
laboratories to greatly enhance our understanding of the catalytic mechanism of hPDH and the structurefunction
relationships of hPDC components and would provide the biochemical basis for some genetic
defects in PDC.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Characterization of interactions of dihydrolipoamide dehydrogenase with its binding protein in the human pyruvate dehydrogenase complex.
人丙酮酸脱氢酶复合物中二氢硫辛酰胺脱氢酶与其结合蛋白相互作用的表征。
DOI:
10.1016/j.bbrc.2010.04.038
发表时间:
2010
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Park,Yun-Hee, Patel,MulchandS]
通讯作者:
Patel,MulchandS
DOI:
10.1080/14756366.2016.1201812
发表时间:
2016
期刊:
Journal of enzyme inhibition and medicinal chemistry
影响因子:
5.6
作者:
[Masini T, Birkaya B, van Dijk S, Mondal M, Hekelaar J, Jäger M, Terwisscha van Scheltinga AC, Patel MS, Hirsch AK, Moman E]
通讯作者:
Moman E
Alpha Lipoic Acid as a Maternal Supplement in Obese Pregnancies
-
批准号:10573241
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2022
-
负责人:MULCHAND S PATEL
-
依托单位:
Alpha Lipoic Acid as a Maternal Supplement in Obese Pregnancies
-
批准号:10373662
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2022
-
负责人:MULCHAND S PATEL
-
依托单位:
Novel drug treatments for pyruvate dehydrogenase complex deficiency
-
批准号:8951447
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2015
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:6369332
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:6928500
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:6525248
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:6607540
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:6785277
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:7581309
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:8134882
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:7902269
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
Maternal Hyperinsulinemia and Fetal Programming
-
批准号:7688614
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2001
-
负责人:MULCHAND S PATEL
-
依托单位:
DIET INDUCED HYPERINSULINEMIA AND BETA CELL FUNCTION
-
批准号:6178036
-
项目类别:
-
资助金额:$23.97万
-
财政年份:1998
-
负责人:MULCHAND S PATEL
-
依托单位:
DIET INDUCED HYPERINSULINEMIA AND BETA CELL FUNCTION
-
批准号:6381291
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1998
-
负责人:MULCHAND S PATEL
-
依托单位:
DIET INDUCED HYPERINSULINEMIA AND BETA CELL FUNCTION
-
批准号:2905898
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1998
-
负责人:MULCHAND S PATEL
-
依托单位:
DIET INDUCED HYPERINSULINEMIA AND BETA CELL FUNCTION
-
批准号:2620415
-
项目类别:
-
资助金额:$24.19万
-
财政年份:1998
-
负责人:MULCHAND S PATEL
-
依托单位:
LONG TERM METABOLIC CONSEQUENCES OF EARLY NUTRITIONAL MODIFICATION
-
批准号:6272000
-
项目类别:
-
资助金额:$13.92万
-
财政年份:1998
-
负责人:MULCHAND S PATEL
-
依托单位:
LONG-TERM METABOLIC CONSEQUENCES OF EARLY NUTRITIONAL MODIFICATION
-
批准号:6240842
-
项目类别:
-
资助金额:$12.67万
-
财政年份:1997
-
负责人:MULCHAND S PATEL
-
依托单位:
DIET INDUCED HYPERINSULINEMIA AND BETA CELL FUNCTION
-
批准号:2328683
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:MULCHAND S PATEL
-
依托单位:
INBORN ERRORS OF PYRUVATE METABOLISM
-
批准号:2872182
-
项目类别:
-
资助金额:$26.12万
-
财政年份:1993
-
负责人:MULCHAND S PATEL
-
依托单位:
海外基金